Will Cognex (CGNX) Gain on Rising Earnings Estimates?

15.05.26 18:20 Uhr

Werte in diesem Artikel
Aktien

57,74 EUR 0,04 EUR 0,07%

1.400,00 JPY 0,00 JPY 0,00%

Indizes

25.297,6 PKT -61,0 PKT -0,24%

935,5 PKT -8,9 PKT -0,94%

Cognex Corporation (CGNX) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.Consensus earnings estimates for the next quarter and full year have moved considerably higher for Cognex Corporation, as there has been strong agreement among the covering analysts in raising estimates.The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:12 Month EPSCurrent-Quarter Estimate RevisionsThe earnings estimate of $0.42 per share for the current quarter represents a change of +68.0% from the number reported a year ago.The Zacks Consensus Estimate for Cognex has increased 70.41% over the last 30 days, as three estimates have gone higher compared to no negative revisions.Current-Year Estimate RevisionsThe company is expected to earn $1.43 per share for the full year, which represents a change of +40.2% from the prior-year number.There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, five estimates have moved up for Cognex versus one negative revision. This has pushed the consensus estimate 41.7% higher.Favorable Zacks RankThe promising estimate revisions have helped Cognex earn a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.Bottom LineCognex shares have added 20.2% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.See Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Cognex und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Cognex Corp.

Analysen zu Cognex Corp.

DatumRatingAnalyst
30.04.2019Cognex HoldNeedham & Company, LLC
15.02.2019Cognex BuyNeedham & Company, LLC
12.02.2019Cognex BuyNeedham & Company, LLC
13.12.2018Cognex BuyNeedham & Company, LLC
30.10.2018Cognex BuyNeedham & Company, LLC
DatumRatingAnalyst
15.02.2019Cognex BuyNeedham & Company, LLC
12.02.2019Cognex BuyNeedham & Company, LLC
13.12.2018Cognex BuyNeedham & Company, LLC
30.10.2018Cognex BuyNeedham & Company, LLC
16.10.2018Cognex BuyNeedham & Company, LLC
DatumRatingAnalyst
30.04.2019Cognex HoldNeedham & Company, LLC
15.03.2017Cognex HoldNeedham & Company, LLC
14.06.2016Cognex HoldCanaccord Adams
11.05.2016Cognex Mkt PerformFBR Capital
11.11.2015Cognex Mkt PerformFBR Capital
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cognex Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen